08/17/2026
Candida auris (Candidozyma auris) is back in the headlines.
According to CDC surveillance data 3,437 cases identified across 27 states through the week ending July 25. Encouragingly, that's fewer than at the same point last year — and CDC notes the annual rate of increase has slowed since 2022. Infection prevention work is having an effect.
Here is what to know about Candidozyma auris:
It survives on bedrails, doorknobs, and shared equipment for extended periods
It moves through hospitals and long-term care facilities among the most vulnerable patients
It remains difficult to treat — in a CDC analysis of more than 8,000 isolates from 2022–2023, over 95% were resistant to fluconazole, a first-line antifungal
The hardest part: colonized patients frequently have no symptoms at all, and they can still transmit. Containment therefore depends on surveillance screening rather than waiting for clinical presentation.
Learn more at IMMY, visit: https://hubs.ly/Q04s-GQw0